Related Experiment Video
Updated: Dec 21, 2025
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
84.2K
Direct-acting Oral Anticoagulants in Dermatologic Surgery
V Cabezas-Calderon1, P Bassas Freixas1, V García-Patos Briones1
1Servicio de Dermatología, Hospital Universitario Vall d'Hebron, Barcelona, España.
Actas Dermo-Sifiliograficas
|May 19, 2020
Summary
Direct-acting oral anticoagulants (DOACs) offer a safer alternative to older blood thinners. This review examines their use in dermatologic surgery, addressing the lack of consensus on perioperative management.
Area of Science:
- Dermatology
- Pharmacology
- Surgery
Background:
- Direct-acting oral anticoagulants (DOACs) are increasingly used due to their safety and ease of use compared to vitamin K antagonists.
- DOACs offer advantages like no required monitoring and fewer drug interactions.
- Optimal perioperative management strategies for DOACs in dermatologic surgery remain unclear.
Purpose of the Study:
- To describe the characteristics of DOACs.
- To review current evidence on the perioperative use of DOACs in dermatologic surgery.
Main Methods:
- Literature review of studies on DOACs and their application in dermatologic surgery.
- Analysis of DOAC properties and clinical evidence.
Main Results:
- DOACs present distinct pharmacokinetic and pharmacodynamic profiles.
- Evidence regarding the management of DOACs during dermatologic procedures is limited and varied.
- Current literature lacks a definitive consensus on best practices.
Conclusions:
- Further research is needed to establish clear guidelines for DOAC management in dermatologic surgery.
- Understanding DOAC characteristics is crucial for safe perioperative care.
- Bridging the knowledge gap in DOAC perioperative use is essential for patient safety.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.8K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
01:29Venous Thrombosis III: Interprofessional Care
209
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
209
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
949
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
949
01:30Venous Thrombosis IV: Nursing Management
148
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
148
01:16Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
992
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
992